SCHEMBL419989

SCHEMBL419989

O=C1N[C@H]2C=C[C@@H]1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8223422 1.00
SCHEMBL548616 1.00
SCHEMBL5397907 0.70 ALDH1A1 (0.36)
SCHEMBL19250783 0.65
SCHEMBL9587213 0.54 TDP1 (0.35)
SCHEMBL12154365 0.54
SCHEMBL1411619 0.54
SCHEMBL6202105 0.54
SCHEMBL2979101 0.53
Noreximide SCHEMBL14536593 0.51 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122012644-A Method for preparing chiral compound by resolving racemization lactam and application thereof 中国食品药品检定研究院 2026-05-12 CN claimed
US-12331006-B2 Process for the synthesis of (s) 3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid NORTHWESTERN UNIVERSITY (US) 2025-06-17 US claimed
EP-3784649-B1 PROCESS FOR THE SYNTHESIS OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID UNIV NORTHWESTERN (US) 2024-07-31 EP claimed
CN-117550990-A Process for the synthesis of (S) -3-amino-4- (difluoromethylene) cyclopent-1-ene-1-carboxylic acid 西北大学 2024-02-13 CN claimed
CN-112513006-B Process for the synthesis of (S) -3-amino-4- (difluoromethylene) cyclopent-1-ene-1-carboxylic acid 西北大学 2023-10-31 CN claimed
US-20210139412-A1 PROCESS FOR THE SYNTHESIS OF (S) 3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID NORTHWESTERN UNIVERSITY 2021-05-13 US claimed
US-10836708-B2 Process for the synthesis of (s) 3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid NORTHWESTERN UNIVERSITY (US) 2020-11-17 US claimed
US-6723868-B1 REDUCING 2-AZABICYCLO(2.2.1)HEPT-5-EN-1-ONE WITH LITHIUM BOROHYDRIDE TO FORM 1-AMINO-4-(HYDROXYMETHYL)-2- CYCLOPENTENE LONZA AG (CH) 2004-04-20 US claimed
EP-1003903-B1 PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED N-DERIVATISED LACTAMS GLAXO GROUP LTD (GB) 2003-02-26 EP claimed
US-6448402-B2 REDUCTION OF 2-AZABICYCLO(2.2.1)HEPT-5-EN-3-ONE USING METAL HYRIDE LONZA AG (CH) 2002-09-10 US claimed
US-6340587-B1 TREATING RACEMIC MIXTURE WITH ACYLASE; ISOLATING PURE ENANTIOMORPH OF N-PROTECTED (1R,4S)-2-AZABICYCLO(2.2.1)HEPT-5-EN-3-ONE SMITHKLINE BEECHAM CORPORATION 2002-01-22 US claimed
US-20260144795-A1 SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS H. LUNDBECK A/S (DK) 2026-05-28 US disclosed
US-20260138979-A1 PROCESSES FOR PREPARING KRAS INHIBITORS INCYTE CORP (US) 2026-05-21 US disclosed
CN-122012644-A Method for preparing chiral compound by resolving racemization lactam and application thereof 中国食品药品检定研究院 2026-05-12 CN disclosed
WO-2026090336-A1 PROCESSES FOR PREPARING KRAS INHIBITORS INCYTE CORPORATION (US) 2026-04-30 WO disclosed
US-6340587-B1 TREATING RACEMIC MIXTURE WITH ACYLASE; ISOLATING PURE ENANTIOMORPH OF N-PROTECTED (1R,4S)-2-AZABICYCLO(2.2.1)HEPT-5-EN-3-ONE SMITHKLINE BEECHAM CORPORATION 2002-01-22 US disclosed
US-6340587-B1 TREATING RACEMIC MIXTURE WITH ACYLASE; ISOLATING PURE ENANTIOMORPH OF N-PROTECTED (1R,4S)-2-AZABICYCLO(2.2.1)HEPT-5-EN-3-ONE SMITHKLINE BEECHAM CORPORATION 2002-01-22 US disclosed
US-6051575-A RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIINFLAMMATORY AGENTS SCHERING CORPORATION (US) 2000-04-18 US disclosed
US-5968929-A USEFUL IN THE TREATMENT OF CHRONIC AIRWAY DISEASES SUCH AS ASTHMA SCHERING CORPORATION (US) 1999-10-19 US disclosed
EP-0926131-A2 Process for the preparation of aminoalcohol derivatives and their further transformation zu (1R,4S)-4-((2-amino-6-chlor-5-formamido-4-pyrimidinyl)-amino)-2-cyclopenten-1-methanol LONZA A.G. (CH) 1999-06-30 EP disclosed